Neurological complications of Zika virus infection

Expert Review of Anti-Infective Therapy

Volumn 16, Issue 5, 2018, Pages 399-410

  Carod Artal, Francisco Javier ^a,b  

^a RAIGMORE HOSPITAL   (United Kingdom)

^b UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

Author keywords

Congenital Zika virus syndrome; encephalitis; flavivirus; Guillain Barr syndrome; microcephaly; myelitis; Zika virus

Indexed keywords

VIRUS RNA;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; BLOOD ANALYSIS; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CONGENITAL INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FETUS BRAIN; GUILLAIN BARRE SYNDROME; HUMAN; MENINGOENCEPHALITIS; MICROCEPHALY; MYELITIS; NEUROIMAGING; NEUROLOGICAL COMPLICATION; NEUROOPHTHALMOLOGY; PLACENTA; POLYNEUROPATHY; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEIZURE; SYMPTOM; UMBILICAL CORD; VASCULAR DISEASE; VIRUS TRANSMISSION; ZIKA FEVER; ANIMAL; COMPLICATION; FEMALE; INCIDENCE; MOSQUITO VECTOR; NEUROLOGIC DISEASE; NEWBORN; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; VERTICAL TRANSMISSION; VIROLOGY;

ANIMALS; DISEASE OUTBREAKS; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; INCIDENCE; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MOSQUITO VECTORS; NERVOUS SYSTEM DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; ZIKA VIRUS INFECTION;

EID: 85047135363     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1080/14787210.2018.1466702     Document Type: Review

References (97)

1. Deseda CC., Epidemiology of Zika. Curr Opin Pediatr. 2017;29:97–101.
2. Baud D, Gubler DJ, Schaub B, et al. An update on Zika virus infection. Lancet. 2017;390:2099–2109.
3. Simpson DI., Zika virus infection in man. Trans R Soc Trop Med Hyg. 1964;58:335–338.
4. Song BH, Yun SI, Woolley M, et al. Zika virus: history, epidemiology, transmission and clinical presentation. J Neuroinmunology. 2017;308:50–64.
5. Macnamara FN. Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria. Trans R Soc Trop Med Hyg. 1954;48:139–145.
6. Fagbami A. Epidemiological investigations on arbovirus infections at Igbo-Ora, Nigeria. Trop Geogr Med. 1977;29:187–191.
7. Gatherer D, Kohl A. Zika virus: a previously slow pandemic spreads rapidly through the Americas. J Gen Virol. 2016;97:269–273.
8. Carod-Artal FJ. Epidemiology and neurological complications of infection by the Zika virus: a new emerging neurotropic virus. Rev Neurol. 2016;62:317–328.
9. Marchette NJ, Garcia R, Rudnick A. Isolation of Zika virus from Aedes aegypti mosquitos in Malaysia. Am J Trop Med Hyg. 1969;18:411–415.
10. Duffy MR, Chen TH, Wt H, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med. 2009;360:2536–2543.
11. Roth A, Mercier A, Lepers C, et al. Concurrent outbreaks of dengue, chikungunya and Zika virus infections –an unprecedented epidemic wave of mosquito borne viruses in the Pacific 2012–2014. Euro Surveill. 2014;19:20929.
12. Cao-Lormeau VM, Blake A, Mons S, et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387:1531–1539.
13. World Health Organization. Zika virus situation report 10 March 2017. [cited 2018 Jan3]. Available from: http://www.who.int/emergencies/Zika-virus/situation-report/10-march-2017/en
14. Enfissi A, Codrington J, Roosblad J, et al. Zika virus genome from the Americas. Lancet. 2016;387:227.
15. Swaminathan S, Schlaberg R, Lewis J, et al. Fatal Zika virus infection with secondary nonsexual transmission. N Engl J Med. 2016;375:1907–1909.
16. CDC. Zika Virus. Centers for Disease Control and Prevention, Atlanta, GA; [cited 2018 Mar10]. Available from: http://www.cdc.gov/zika/index.html
17. Pan American Health Organization. Guidelines for surveillance of Zika virus disease and its complications. Washington, DC: PAHO; 2016.
18. Parra B, Lizarazo J, Jiménez-Arango JA, et al. Guillain-Barré syndrome associated with Zika virus infection in Colombia. N Engl J Med. 2016;375:1513–1523.
19. Magalhaes-Barbosa MC, Prata-Barbosa A, Robaina JR, et al. Trends of the microcephaly and Zika virus outbreak in Brazil, January-July 2016. Travel Med Infect Dis. 2016;14:458–463.
20. Cauchemez S, Besnard M, Bompard P, et al. Association between Zika virus and microcephaly in French Polynesia, 2013–15: a retrospective study. Lancet. 2016;387:2125–2132.
21. Jouannic JM, Friszer S, Leparc-Goffart I, et al. Zika virus infection in French Polynesia. Lancet. 2016;387:1051–1052.
22. Oliveira-Melo AS, Malinger G, Ximenes R, et al. Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg? Ultrasound Obstet Gynecol. 2016;47:6–7.
23. Mlakar J, Korva M, Tul N, et al. Zika virus associated with microcephaly. N Engl J Med. 2016;374:951–958.
24. Calvet G, Aguiar RS, Melo ASO, et al. Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect Dis. 2016;16:653–660.
25. Schwatz DA. Viral infection, proliferation, and hyperplasia of Hofbauer cells and absence of inflammation characterize the placental pathology of fetuses with congenital Zika virus infection. Arch Gynecol Obstet. 2017;295:1361–1368.
26. Sarno M, Sacramento GA, Khouri R, et al. Zika virus infection and stillbirths: a case of hydrops fetalis, hydranencephaly and fetal demise. PLoS Negl Trop Dis. 2016;10:e0004517.
27. Chimelli L, Melo ASO, Avvad-Portari E, et al. The spectrum of neuropathological changes associated with congenital Zika virus infection. Acta Neuropathol. 2017;133:983–999.
28. Eppes C, Rac M, Dunn J, et al. Testing for Zika virus infection in pregnancy: key concepts to deal with an emerging epidemic. Am J Obstet Gynecol. 2017;216:209–225.
29. Zacharias N, Whitty J, Noblin S, et al. First neonatal demise with travel-associated Zika virus infection in the United States of America. AJP Rep. 2017;7:e68–e73.
30. Tang H, Hammack C, Ogden SC, et al. Zika virus infects human cortical neural progenitors and attenuates their growth. Cell Stem Cell. 2016;18:587–590.
31. Huang WC, Abraham R, Shim BS, et al. Zika virus infection during the period of maximal brain growth causes microcephaly and corticospinal neuron apoptosis in wild type mice. Sci Rep. 2016;6:34793.
32. Saad T, PennaeCosta AA, de Góes FV, et al. Neurological manifestations of congenital Zika virus infection. Childs Nerv Syst.2018;34:73–78.
33. Brasil P, Pereira JP, Raja Gabaglia C, et al. Zika virus infection in pregnant women in Rio de Janeiro–preliminary report. N Engl J Med. 2016;375:2321–2334.
34. Chibueze EC, Tirado V, Lopes KS, et al. Zika virus infection in pregnancy: a systematic review of disease course and complications. Reproductive Health. 2017;14:28.
35. Honein MA, Dawson AL, Petersen EE, et al. Birth defects among foetuses and infants of US women with evidence of possible Zika virus infection during pregnancy. Jama. 2017;317:59–68.
36. Schuler-Faccini L, Ribeiro EM, Feitosa IM, et al. Brazilian Medical Genetics Society-Zika Embryopathy Task Force. Possible association between Zika virus infection and microcephaly-Brazil, 2015. MMWR Morb Mortal Wkly Rep. 2016;65:59–62.
37. Moura da Silva AA, Ganz JS, Sousa PD, et al. Early growth and neurological outcomes of infants with probable congenital Zika virus syndrome. Emerg Infect Dis. 2016;22:1953–1956.
38. de Souza AS, de Oliveira-Szjenfeld PS, de Oliveira Melo AS, et al. Imaging findings in congenital Zika virus infection syndrome: an update. Childs Nerv Syst. 2018;34:85-93.
39. Moore CA, Staples JE, Dobyns WB, et al. Characterizing the pattern of anomalies in congenital Zika syndrome for pediatric clinicians. JAMA Pediatr. 2017;171:288–295.
40. Aragão MFVV, Brainer-Lima AM, Holanda AC, et al. Spectrum of spinal cord, spinal root, and brain MRI abnormalities in congenital Zika syndrome with and without arthrogryposis. AJNR Am J Neuroradiol. 2017;38:1045–1053.
41. van der Linden V, Filho EL, Lins OG, et al. Congenital Zika syndrome with arthrogryposis: retrospective case series study. BJM. 2016;354:i3899.
42. Satterfield-Nash A, Kotzky K, Allen J, et al. Health and development at age 19–24 months of 19 children who were born with microcephaly and laboratory evidence of congenital Zika virus infection during the 2015 Zika virus outbreak - Brazil, 2017. MMWR Morb Mortal Wkly Rep. 2017;66:1347–1351.
43. Oliveira-Szejnfeld OS, Levine D, Melo ASO, et al. Congenital brain abnormalities and Zika virus: what the radiologist can expect to see prenatally and postnatally. Radiology. 2016;281:203–218.
44. Ventura CV, Maia M, Bravo-Filho V, et al. Zika virus in Brazil and macular atrophy in a child with microcephaly. Lancet. 2016;387:228.
45. De Paula-Freitas B, De Oliveira-Dias JR, Prazeres J, et al. Ocular findings in infants with microcephaly associated with presumed Zika virus congenital infection in Salvador, Brazil. JAMA Ophthalmol. 2016;134:529–535.
46. Jampol LM, Goldstein DA. Zika virus infection and the eye. JAMA Ophthalmol 2016;134:535-536.
47. Ventura CV, Maia M, Dias N, et al. Zika: neurological and ocular findings in infant without microcephaly. Lancet. 2016;387:2502.
48. Furtado JM, Espósito DL, Klein TM, et al. Uveitis associated with Zika virus infection. N Engl J Med. 2016;375:394–396.
49. Parke DW, Almeida DRP, Albini TA, et al. Serologically confirmed Zika-related unilateral acute maculopathy in an adult. Ophthalmology. 2016. DOI:10.1016/j.optha.2016.06.039.
50. Dirlikov E, Major CG, Mayshack M, et al. Guillain-Barre syndrome during ongoing Zika virus transmission–Puerto Rico, January 1-July 31, 201. MMWR. 2016;65:910–914.
51. Carod-Artal FJ, Wichmann O, Farrar J, et al. Neurological complications of dengue virus infection. Lancet Neurol. 2013;12:906–919.
52. Krauer F, Riesen M, Reveiz L, et al.; WHO Zika Causality Working Group. Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barré syndrome: systematic review. PLoS Med. 2017;14:e1002203.
53. Oehler E, Watrin L, Larre P, et al. Zika virus infection complicated by Guillain-Barre syndrome-case report, French Polynesia, December 2013. Euro Surveill. 2014;19:20720.
54. Dos Santos T, Rodriguez A, Almiron M, et al. Zika virus and the Guillain-Barré syndrome - case series from seven countries. N Engl J Med. 2016;375:1598–1601.
55. Méndez N, Oviedo-Pastrana M, Mattar S, et al. Zika virus disease, microcephaly and Guillain-Barré syndrome in Colombia: epidemiological situation during 21 months of the Zika virus outbreak, 2015–2017. Arch Public Health. 2017;75:65.
56. Salinas JL, Walteros DM, Styczynski A, et al. Zika virus disease-associated Guillain-Barré syndrome-Barranquilla, Colombia 2015–2016. J Neurol Sci. 2017;381:272–277.
57. Watrin L, Ghawché F, Larre P, et al. Guillain-Barré syndrome (42 cases) occurring during a zika virus outbreak in French Polynesia. Medicine. 2016;95:e3257.
58. Villamil-Gomez WE, Sánchez-Herrera ÁR, Hernandez H, et al. Guillain-Barré syndrome during the Zika virus outbreak in Sucre, Colombia, 2016. Travel Med Infect Dis. 2017;16:62–63.
59. Reyna-Villasmil E, López-Sánchez G, Santos-Bolívar J. Guillain-Barré syndrome due to Zika virus during pregnancy. Med Clin (Barc). 2016;146:331–332.
60. Resier D, Ferge JL, Fabre J, et al. Cardiovascular complications in patients with Zika virus-induced Guillain-Barre syndrome. J Clin Virol. 2018;98:8–9.
61. Miller E, Becker Z, Shalev D, et al. Probable Zika virus-associated Guillain-Barré syndrome: challenges with clinico-laboratory diagnosis. J Neurol Sci. 2017;375:367–370.
62. da Silva IRF, Frontera JA, Bispo de Filippis AM, et al.; RIO-GBS-ZIKV Research Group. Neurologic complications associated with the Zika virus in Brazilian adults. JAMA Neurol. 2017;74:1190–1198.
63. Uncini A, Shahrizaila N, Kuwabara S. Zika virus infection and Guillain-Barré syndrome: a review focused on clinical and electrophysiological subtypes. J Neurol Neurosurg Psychiatry. 2017;88:266–271.
64. Fabrizius RG, Anderson K, Hendel-Paterson B, et al. Guillain-Barré syndrome associated with Zika virus infection in a traveller returning from Guyana. Am J Trop Med Hyg. 2016;95:1161–1165.
65. Sejvar JJ, Kohl KS, Gidudu J, et al. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29:599–612.
66. Leis AA, Stokic DS. Zika virus and Guillain-Barre syndrome: is there sufficient evidence for causality? Front Neurol. 2016;7:170.
67. Medina MT, England JD, Lorenzana I, et al. Zika virus associated with sensory polyneuropathy. J Neurol Sci. 2016;369:271–272.
68. Martinez ARM, Costa MCM, Novaes MAC, et al. A novel phenotype of Zika virus-related neurological disease: sensory neuronopathy. Muscle Nerve. 2017; published online 6 September 2017. DOI:10.1002/mus.25958
69. Lira Cleto T, Falcão de Araújo L, Grazielle Capuano K, et al. Peripheral neuropathy associated with Zika virus infection. Pediatric Neurology. 2016;65:e1ee2.
70. Nascimento OJM, Frontera JA, Amitrano DA, et al.; RIO-GBS-ZIKV Research Group. Zika virus infection-associated acute transient polyneuritis. Neurology. 2017;88:2330–2333.
71. Carod Artal FJ. Infectious diseases causing autonomic dysfunction. Clin Auton Res. 2018;28:67-81.
72. Carod Artal FJ. Autonomic dysfunction: a novel neurological phenotype associated with Zika virus infection? Clin Auton Res. 2018;28:161–163.
73. Rodriguez Y, Rojas M, Ramirez-Santana C, et al. Autonomic symptoms following Zika virus infection. Clin Auton Res. 2018;28:211–214.
74. Carteaux G, Maquart M, Bedet A, et al. Zika virus associated with meningoencephalitis. N Engl J Med. 2016;374:1595–1596.
75. Sarmiento-Ospina A, Vasquez-Serna H, Jimenez-Canizales CE, et al. Zika virus associated deaths in Colombia. Lancet Infect Dis. 2016;16:523–524.
76. Soares CN, Brasil P, Carrera RM, et al. Fatal encephalitis associated with Zika virus infection in an adult. J Clin Virol. 2016;83:63–65.
77. Pradhan F, Burns JD, Agameya A, et al. Case report: Zika virus meningoencephalitis and myelitis and associated magnetic resonance imaging findings. Am J Trop Med Hyg. 2017;97:340–343.
78. Ugarte SU, Arenas ARV, Alvarez BC, et al.; LACCTIN group. Zika virus-induced neurological critical illness in Latin America: severe Guillain-Barre syndrome and encephalitis. J Crit Care. 2017;42:275–281.
79. Brito Ferreira ML, Antunes de Brito CA, Moreira ÁJP, et al. Guillain-Barré syndrome, acute disseminated encephalomyelitis and encephalitis associated with Zika virus infection in Brazil: detection of viral RNA and isolation of virus during late infection. Am J Trop Med Hyg. 2017;97:1405–1409.
80. Niemeyer B, Niemeyer R, Borges R, et al. Acute disseminated encephalomyelitis following zika virus infection. Eur Neurol. 2017;77:45–56.
81. Galliez RM, Spitz M, Rafful PP, et al. Zika virus causing encephalomyelitis associated with immunoactivation. Open Forum Infect Dis. 2016;3:ofw203.
82. Mécharles S, Herrmann C, Poullain P, et al. Acute myelitis due to Zika virus infection. Lancet. 2016;387:1481.
83. Palacios E, Clavijo-Prado C, Ruiz A, et al. A diagnostic challenge in a hospital in Colombia. Neurologia. 2016; published online 21 October 2016. DOI:10.1016/j.nrl.2016.08.006
84. Anaya JM, Rodríguez Y, Monsalve DM, et al. A comprehensive analysis and immunobiology of autoinmune neurological syndromes during the Zika virus outbreak in Cúcuta, Colombia. J Autoimmunity. 2017;77:123–138.
85. Carod Artal FJ. Clinical management of infectious cerebral vasculitides. Expert Review Neurotherap. 2016;16:205–221.
86. Landais A, Césaire A, Fernandez M, et al. ZIKA vasculitis: a new cause of stroke in children? J Neurol Sci. 2017; published online 27 October 2017. DOI:10.1016/j.jns.2017.10.045
87. Mulkey SB, Vezina G, Bulas D, et al. Neuroimaging findings in normocephalic newborns with intrauterine Zika virus exposure. Pediatr Neurol. 2018;81:55-56.
88. Schaub B, Gueneret M, Jolivet E, et al. Ultrasound imaging for identification of cerebral damage in congenital Zika virus syndrome: a case series. Lancet Child Adolesc Health. 2017;1:45–55.
89. Rozé B, Najioullah F, Signate A, et al. Zika virus detection in cerebrospinal fluid from two patients with encephalopathy, Martinique, February 2016. Euro Surveill Bull Eur Sur Malo Transm Eur Commun Dis Bull. 2016;21(16):pii=30205.
90. Machado-Alba JE, Machado-Duque ME, Gaviria-Mendoza A, et al. Diagnosis of neurological disorders and the Zika virus epidemic in Colombia 2014–2016. Int J Infect Dis. 2016;51:133–134.
91. World Health Organization. Zika virus research agenda.[updated Oct 2016; cited 2018 Jan 3]. Available from: http://www.who.int/reproductivehealth/zika/zika-virus-reserach-agenda/en/
92. Gold CA, Josephson SA. Anticipating the challenges of Zika virus and the incidence of Guillain-Barre syndrome. JAMA Neurol. 2016;73:905–906.
93. Abrams RPM, Solis J, Nath A. Therapeutic approaches for Zika virus infection of the nervous system. Neurotherapeutics. 2017;14:1027-1048.
94. McArthur M. Zika Virus: recent advances towards the development of vaccines and therapeutics. Viruses. 2017;9:143.
95. Larocca RA, Abbink P, Peron JP, et al. Vaccine protection against Zika virus from Brazil. Nature. 2016;536:474–478.
96. Tebas P, Roberts CC, Muthumani K, et al. Safety and immunogenicity of an anti-Zika virus DNA vaccine - preliminary report. N Engl J Med. 2017; published online 4 October 2017. DOI:10.1056/NEJMoa1708120
97. Gaudinski MR, Houser KV, Morabito KM, et al.; VRC 319; VRC 320 study teams. Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials. Lancet. 2018;391:552-562